One of the actual controllers and Chairman of Aidi Pharmaceutical, Fu Heliang, plans to increase his holdings in the company by 10 million to 15 million yuan.

NightAirdropper · 2026-03-01T13:48:47+00:00

Chairman Fu Heliang of Aidi Pharmaceuticals announced that he will increase his holdings in the company within six months starting from March 2nd. The planned increase will be between 10 million and 15 million yuan to boost investor confidence and support the company's development.

NightAirdropper

2026-03-01 13:48:47

Abstract generation in progress

Beijing Business Daily News (Reporter Ding Ning) reported that on the evening of March 1, Aidi Pharmaceutical (688488) announced that, based on confidence in the company’s future development and recognition of its long-term investment value, as well as to further strengthen investor confidence, protect the interests of the company and all shareholders, and promote the company’s sustainable, stable, and healthy development, one of the company’s actual controllers and Chairman Fu Heliang plans to increase his holdings of the company’s shares within six months starting from March 2 through methods permitted by the Shanghai Stock Exchange trading system (including but not limited to centralized bidding and block trades). The planned amount for the increase is no less than 10 million yuan (inclusive) and no more than 15 million yuan (inclusive).

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

2 Likes